Tvardi Therapeutics, Inc. (TVRD)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
Aug 28, 16:00
1.81
-0.01
(-0.55%)
After-Hours: 20:00
Tvardi Therapeutics Total Liabilities (Quarterly) : 9.135M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.135M |
| March 31, 2026 | 11.31M |
| December 31, 2025 | 11.13M |
| September 30, 2025 | 11.16M |
| June 30, 2025 | 10.82M |
| March 31, 2025 | 47.02M |
| December 31, 2024 | 40.83M |
| September 30, 2024 | 50.62M |
| June 30, 2024 | 60.90M |
| March 31, 2024 | 60.30M |
| December 31, 2023 | 68.76M |
| September 30, 2023 | 29.70M |
| June 30, 2023 | 25.46M |
| March 31, 2023 | 16.68M |
| December 31, 2022 | 23.46M |
| September 30, 2022 | 28.69M |
| June 30, 2022 | 22.15M |
| March 31, 2022 | 19.75M |
| December 31, 2021 | 19.53M |
| September 30, 2021 | 17.90M |
| June 30, 2021 | 17.99M |
| March 31, 2021 | 19.77M |
| December 31, 2020 | 22.16M |
| September 30, 2020 | 19.29M |
| June 30, 2020 | 27.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.70M |
| December 31, 2019 | 46.25M |
| September 30, 2019 | 51.90M |
| June 30, 2019 | 50.10M |
| March 31, 2019 | 56.06M |
| December 31, 2018 | 57.19M |
| September 30, 2018 | 63.17M |
| June 30, 2018 | 66.82M |
| March 31, 2018 | 8.532M |
| December 31, 2017 | 10.22M |
| September 30, 2017 | 8.973M |
| June 30, 2017 | 8.753M |
| March 31, 2017 | 14.03M |
| December 31, 2016 | 13.10M |
| September 30, 2016 | 8.35M |
| June 30, 2016 | 9.457M |
| March 31, 2016 | 7.086M |
| December 31, 2015 | 5.853M |
| September 30, 2015 | 4.034M |
| June 30, 2015 | 3.971M |
| March 31, 2015 | 4.23M |
| December 31, 2014 | 4.272M |
| September 30, 2014 | 7.037M |
| June 30, 2014 | 6.626M |
| March 31, 2014 | 6.827M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 108.40B |
| Crinetics Pharmaceuticals, Inc. | 129.92M |
| Liquidia Corp. | 326.80M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.52M |
| Shareholders Equity (Quarterly) | 8.382M |
| Debt to Equity Ratio | 0.0173 |
| Current Ratio | 1.873 |
| Net Debt Paydown Yield | 51.25% |